AAV Product Quality Through In-line PAT

Working alongside Cell & Gene Therapy Catapult, Pharmaron has adapted an off-line analytical technology, utilizing Malvern’s OMNISEC REVEAL that has the potential to significantly reduce Process Development timelines.

To learn more about how this technology can lead to improved, cost-effective AAV PD timelines, give increased understanding on product quality and control of downstream processing from early stages of development, please complete the form below to download the poster: Advancing AAV product quality through use of in-line PAT in DSP.

Name(Required)

First Last

Company Name(Required)

Job Title(Required)

Country(Required)

State(Required)

Message

Email(Required)

This field is hidden when viewing the form

Lead Source(Required)

By completing and submitting this form, you acknowledge that you have read and understood our Privacy Policy, and you consent to the collection and processing of your personal data by Pharmaron for the purpose of responding to your inquiry. You also agree to be contacted by Pharmaron regarding relevant services and updates. You may withdraw your consent at any time.